As at Nov 21, 2024, the AVNS stock has a price-to-earnings ratio of 51.49. This is based on the current EPS of $0.35 and the stock price of $18.02 per share.
The mean historical PE ratio of Avanos Medical over the last ten years is 76.12. The current 51.49 PE ratio is 32% below the historical average. In the past ten years, AVNS's PE ratio was at its highest in the Mar 2015 quarter at 307.5, with a price of $49.2 and an EPS of $0.16. The Sep 2022 quarter recorded the bottom point at 22.69, with a price of $21.78 and an EPS of $0.96.
Maximum annual increase: 34.32% in 2018
Maximum annual decrease: -90.6% in 2022
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | 25.06 | -90.6% |
2021 | 266.69 | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | 36.71 | 34.32% |
2017 | 27.33 | -37.19% |
2016 | 43.51 | N/A |
2015 | N/A | N/A |
2014 | 78.4 | N/A |
The current PE ratio of AVNS is lower than the 3, 5 and 10-year averages.
Compared to its peer stocks SYK and STE, AVNS's PE ratio stands higher.
Stock name | PE ratio | Market cap |
---|---|---|
SYK Stryker Corp | 41.37 | $148.73B |
STE STERIS plc | 49.04 | $21.3B |
AVNS Avanos Medical Inc | 51.49 | $828.15M |
The price to earnings ratio for AVNS stock is 51.49 as of Nov 21, 2024.
The average PE ratio for AVNS stock over the past 3 years is 87.52.
The average PE ratio for AVNS stock over the past 5 years is 90.42.
The highest quarterly PE ratio in the last ten years has been 307.5 and it was in the Mar 2015 quarter.
AVNS's current price to earnings ratio is 32% below its 10-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Nov 21, 2024), Avanos Medical's stock price is $18.02. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.35. Therefore, Avanos Medical's P/E ratio for today is 51.49. PE RATIO(51.49) = STOCK PRICE($18.02) / TTM EPS($0.35)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.